Incarceration among young injectors in San Francisco: Associations with risk for hepatitis C virus infection

Journal of Substance Use

Volumn 11, Issue 4, 2006, Pages 271-281

  Kittikraisak, W ^a   Davidson, P J ^b   Hahn, J A ^c   Lum, P J ^b   Evans, J L ^d   Moss, A R ^b   Page Shafer, K ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis; HIV; Incarceration; Injection drug user; Jail; Youth

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BEHAVIORAL RESEARCH; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG ABUSE; EDUCATION; FEMALE; HEALTH BEHAVIOR; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HOMELESSNESS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRISON; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SEX DIFFERENCE; UNITED STATES;

EID: 33748292944     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.1080/14659890500420095     Document Type: Article

References (37)

1. Association of State and Territorial Health Officials.(1999). In Why public health should go to jail. Washington DC: The Association of State and Territorial Health Officials.
2. Association of State and Territorial Health Officials.(2000). In Hepatitis C and incarcerated populations - the next wave for correctional health initiatives. Washington DC: The Association of State and Territorial Health Officials.
3. Beyrer, C. and Jittiwutikarn, J. and Teokul, W. and Razak, M. H. and Suriyanon, V. and Srirak, N. and (2003) Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS and Behavior, 7((2)), pp. 153-61.
4. Bird, A. G. and Gore, S. M. and Burns, S. M. and Duggie, J. G. (1993) Study of infection with HIV and related risk factors in young offenders' institution. British Medical Journal, 307((6898)), pp. 228-31.
5. Clarke, J. G. and Stein, M. D. and Hanna, L. and Sobota, M. and Rich, J. D. (2001) Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Substance Abuse, 22((4)), pp. 209-16.
6. Clements, K. and Gleghorn, A. and Garcia, D. and Katz, M. and Marx, R. (1997) A risk profile of street youth in northern California: implications for gender-specific human immunodeficiency virus prevention. Journal of Adolescent Health, 20((5)), pp. 343-53.
7. Cook, P. A. and McVeigh, J. and Syed, Q. and Mutton, K. and Bellis, M. A. (2001) Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction, 96((12)), pp. 1787-97.
8. Crofts, N. and Aitken, C. K. (1997) Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Medical Journal of Australia, 167((1)), pp. 17-20.
9. Fox, R. K. and Currie, S. L. and Evans, J. and Wright, T. L. and Tobler, L. and Phelps, B. and Busch, M. L. and Page-Shafer, K. (2005) Hepatitis C virus among prisoners in the California State Correctional System. Clinical Infectious Diseases, 41((2)), pp. 177-186.
10. Freudenberg, N. (2001) Jails, prisons, and the health of urban populations: A review of the impact of the correctional system on community health. Journal of Urban Health, 78((2)), pp. 214-35.
11. Garfein, R. S. and Doherty, M. C. and Monterroso, E. R. and Thomas, D. L. and Nelson, K. E. and Vlahov, D. (1998) Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18((5), Suppl 1), pp. S11-S19.
12. Garfein, R. S. and Vlahov, D. and Galai, N. and Doherty, M. C. and Nelson, K. E. (1996) Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86((5)), pp. 655-61.
13. Hagan, H. and Des Jarlais, D. C. (2000) HIV and HCV infection among injecting drug users. Mount Sinai Journal of Medicine, 67((5/6)), pp. 423-8.
14. Hahn, J. A. and Page-Shafer, K. and Lum, P. J. and Bourgois, P. and Stein, E. and Evans, J. L. and (2002) Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Diseases, 186((11)), pp. 1558-64.
15. Hahn, J. A. and Page-Shafer, K. and Lum, P. J. and Ochoa, K. and Moss, A. R. (2001) Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology, 34((1)), pp. 180-7.
16. Hammett, T. and Harmon, M. and Rhodes, W. (2002) The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. American Journal of Public Health, 92((11)), pp. 1789-94.
17. Kennedy, D. H. and Nair, G. and Elliott, L. and Ditton, J. (1995) Drug misuse and sharing of needles in Scottish prisons. British Medical Journal, 302, pp. 1507.
18. Kral, A. H. and Lorvick, J. and Edlin, B. R. (2000) Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. Journal of Acquired Immune Deficiency Syndromes, 24((2)), pp. 162-7.
19. Kral, A. H. and Lorvick, J. and Gee, L. and Bacchetti, P. and Rawal, B. and Busch, M. and (2003) Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. American Journal of Epidemioology, 157((10)), pp. 915-22.
20. Kral, A. H. and Page-Shafer, K. and Edlin, B. R. and Kellogg, T. and Riley, E. and Gee, L. and (2004) Persistent HIV incidence among injection drug users in San Francisco during the 1990s: Results of five studies. Journal of Acquired Immune Deficiency Syndromes, 37((5)), pp. 1667-9.
21. Lopez-Zetina, J. and Kerndt, P. and Ford, W. and Woehle, T. and Weber, M. (2001) Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996. Addiction, 96((4)), pp. 589-95.
22. Lum, P. J. and Ochoa, K. C. and Hahn, J. A. and Page Shafer, K. and Evans, J. L. and Moss, A. R. (2003) Hepatitis B virus immunization among young injection drug users in San Francisco, California: The UFO Study. American Journal of Public Health, 93((6)), pp. 919-23.
23. National Center on Addiction and Substance Use at Columbia University.(1998). In Behind Bars: Substance use and America's prison population. New York: National Center on Addiction and Substance Use at Columbia University.
24. Nelson, K. E. and Vlahov, D. and Solomon, L. and Cohn, S. and Munoz, A. (1995) Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Archives of Internal Medicine, 155((12)), pp. 1305-11.
25. Page Shafer, K. and Hahn, J. A. and Lum, P. J. and Ochoa, K. and Graves, A. and Moss, A. (2002) Prevalence and correlates of HIV infection among young injection drug users in San Francisco. Journal of Acquired Immune Deficiency Syndromes, 31((4)), pp. 422-31.
26. Patrick, D. M. and Strathdee, S. A. and Archibald, C. P. and Ofner, M. and Craib, K. J. and Cornelisse, P. G. and (1997) Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. International Journal of STD & AIDS, 8((7)), pp. 437-45.
27. Pollack, H. and Khoshnood, K. and Altice, F. (1999) Health care delivery strategies for criminal offenders. Journal of Health Care Finance, 26((1)), pp. 63-77.
28. Reindollar, R. W. (1999) Hepatitis C and the correctional population. American Journal of Medicine, 107((6), Suppl. 2), pp. 100-3.
29. Ruiz, J. D. and Molitor, F. and Plagenhoef, J. A. (2002) Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS, 16((16)), pp. 2236-2238.
30. Ruiz, J. D. and Molitor, F. and Sun, R. and Mikanda, J. and Facer, M. and Colford, J. M. Jr. and (1999) Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. Western Journal of Medicine, 170((3)), pp. 156-60.
31. Sorensen, J. L. and Masson, C. L. and Perlman, D. C. (2002) HIV/ hepatitis prevention in drug abuse treatment programs: Guidance from research. Science and Practice Perspectives (July), pp. 4-11.
32. Spaulding, a. and Greene, C. and Davidson, K. and Schneidermann, M. and Rich, J. (1999) Hepatitis C in state correctional facilities. Preventative Medicine, 28((1)), pp. 92-100.
33. Teplin, L. A. and Mericle, A. A. and McClelland, G. M. and Abram, K. M. (2003) HIV and AIDS risk behaviors in juvenile detainees: Implications for public health policy. American Journal of Public Health, 93((6)), pp. 906-12.
34. Thiede, H. and Romero, M. and Bordelon, K. and Hagan, H. and Murrill, C. S. (2001) Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. Journal of Urban Health, 78((2)), pp. 264-78.
35. Thorpe, L. E. and Ouellet, L. J. and Hershow, R. and Bailey, S. L. and Williams, I. T. and Williamson, J. and (2002) Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155((7)), pp. 645-53.
36. US Department of Justice. 2004. Bureau of Justice Statistics. Corrections statistics. www.ojp.usdoj.gov/bjs/
37. Van Beek, I. and Dwyer, R. and Dore, G. J. and Luo, K. and Kaldor, J. M. (1998) Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study [see comments]. British Medical Journal, 317((7156)), pp. 433-7.